[IgA nephropathy--advances of therapy].
Prokopiuk
M
M
Klinika Nefrologii ze Stacja Dializ CSK WAM w Warszawie.
Wierzbicki
P
P
Kade
G
G
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000276:immunology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000927:Anticonvulsants; D015525:Fatty Acids, Omega-3; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors